Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
2.
J Vector Borne Dis ; 59(3): 298-301, 2022.
Artigo em Inglês | MEDLINE | ID: mdl-36511048

RESUMO

Mediterranean spotted fever (MSF) is a tick-borne acute endemic infectious disease caused by Rickettsia conorii. While MSF may progress asymptomatically, it may lead to clinical pictures like severe hemorrhagic fever. In this article, we are presenting an MSF case with signs of high fever, headache, nausea, weakness and generalized maculopapular rash. The diagnosis of the female patient who had a history of contact with a tick-infested dog was confirmed with her clinical and laboratory data. The clinical and laboratory findings of the patient who was given doxycycline by 200 mg/day for 7 days were improved in a short time. Rickettsia conorii serology by indirect immunofluorescence assay method confirmed the diagnosis of MSF. In cases of severe sepsis accompanied by high fever and generalized maculopapular rash where the source of the infection cannot be determined in the short term, carefully questioning exposure to ticks by considering the existing geographical, seasonal and endemic environmental factors may be life-saving in terms of early diagnosis and treatment of MSF, which may become fatal even in the absence of eschars (tache noire). The symptomatology of hemorrhagic fever associated with Rickettsia conorii may be confused with that of sepsis in clinical practice.


Assuntos
Febre Botonosa , Exantema , Sepse , Carrapatos , Feminino , Cães , Animais , Febre Botonosa/diagnóstico , Febre Botonosa/tratamento farmacológico , Febre Botonosa/complicações , Doxiciclina/uso terapêutico , Sepse/diagnóstico , Sepse/tratamento farmacológico , Sepse/complicações , Técnica Indireta de Fluorescência para Anticorpo
4.
Eur J Clin Microbiol Infect Dis ; 40(2): 407-411, 2021 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-32856202

RESUMO

This manuscript aims to present a treatment algorithm we applied to manage COVID-19 patients admitted to our hospital. During the study period, 2043 patients with suspected COVID-19 were admitted to the emergency department. Molecular tests indicated that 475 of these patients tested positive for COVID-19. We administered hydroxychloroquine plus doxycycline to mild cases (isolated at home) for 3 days and lopinavir plus doxycycline to moderate and severe cases (hospitalized) for 5 days. The overall case fatality rate was 4.2% (20/475).


Assuntos
Tratamento Farmacológico da COVID-19 , Doxiciclina/administração & dosagem , Lopinavir/administração & dosagem , SARS-CoV-2 , Idoso , Idoso de 80 Anos ou mais , Estudos de Coortes , Quimioterapia Combinada , Feminino , Humanos , Hidroxicloroquina/administração & dosagem , Masculino , Pessoa de Meia-Idade
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...